Risk Factors for Venous Thromboembolism in Patients With Small Cell Lung Cancer

Medical records of sequential, non-selected patients with lung cancer who were treated at the Oncology Unit, Sotiria General Hospital, Athens, Greece between January 2015 and June 2018 were reviewed. Download pdf...

Lung Cancer in Greece

Greece is a South European country, located at the east part of the Mediterranean basin and the southern edge of the Balcan Peninsula, with a population of 10,720,000 in 2019.In...

Clinical utility of thoracic endosonography (EBUS/EUS-b) in mediastinal staging of patients with non-small cell lung cancer: comparison with integrated PET/CT—a real-life prospective study in Greece

“Clinical utility of thoracic endosonography (EBUS-EUS b) in mediastinal staging of patients with Non Small Lung Cancer : comparison with intergrated PET-CT – a real life prospective study in...

Modern Radiopharmaceuticals for lung cancer imaging with positron emission tomography/ computed tomography scan: A systematic review

“Modern Radiopharmaceuticals for lung cancer imaging with positron emission tomography/ computed tomography scan: A systematic review” by Athanasios Theodoropoulos, Ioannis Gkiozos, Georgios Kontopyrgias et all, in SAGE Open Med. 2020,...

Sarcoidosis-Like Reactions Induced by Checkpoint Inhibitors

Immune checkpoint inhibitors (ICIs) are a newly developed component of cancer care that expands the treatment possibilities for patients. Their use has been associated with several immune-related adverse events, including...

PET/CT and brain MRI role in staging NSCLC: prospective assessment of the accuracy, reliability and cost–effectiveness

To determine whether PET/CT and brain MRI used in staging NSCLC can be accurate, reliable and cost-effective tools. NSCLC represents 80–85% of lung cancer and adequate information on the initial...